17.99
price down icon7.12%   -1.38
 
loading
Precedente Chiudi:
$19.37
Aprire:
$18.2
Volume 24 ore:
313.26K
Relative Volume:
1.20
Capitalizzazione di mercato:
$256.54M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+22.13%
1M Prestazione:
+67.04%
6M Prestazione:
-47.88%
1 anno Prestazione:
-46.65%
Intervallo 1D:
Value
$15.68
$18.89
Intervallo di 1 settimana:
Value
$13.93
$19.51
Portata 52W:
Value
$6.875
$74.49

Neurogene Inc Stock (NGNE) Company Profile

Name
Nome
Neurogene Inc
Name
Telefono
(877) 237-5020
Name
Indirizzo
535 W 24TH STREET, NEW YORK
Name
Dipendente
107
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
NGNE's Discussions on Twitter

Confronta NGNE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NGNE
Neurogene Inc
17.99 210.08M 0 0 0 0.00
Biotechnology icon
ONC
Beigene Ltd Adr
228.38 25.07B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.65 109.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.27 36.39M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
594.32 56.98B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
71.31 5.39B 0 -153.72M -103.81M -2.00

Neurogene Inc Stock (NGNE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-27 Iniziato BMO Capital Markets Outperform
2024-06-11 Iniziato Robert W. Baird Outperform
2024-04-29 Iniziato Leerink Partners Outperform
2024-03-21 Iniziato William Blair Outperform
2024-01-08 Iniziato H.C. Wainwright Buy
2024-01-05 Iniziato Stifel Buy
2024-01-04 Iniziato TD Cowen Outperform
Mostra tutto

Neurogene Inc Borsa (NGNE) Ultime notizie

pulisher
01:33 AM

Brokerages Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $46.20 - Defense World

01:33 AM
pulisher
May 16, 2025

Neurogene Shares Drop After Downgrade From Baird - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Neurogene stock downgraded at Baird (NGNE:NASDAQ) - Seeking Alpha

May 16, 2025
pulisher
May 16, 2025

Neurogene (NGNE) Downgraded to Neutral with Lowered Price Target | NGNE Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Neurogene (NGNE) Presents New Protocol for Tackling Gene Therapy - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Neurogene presents HLH treatment strategy at ASGCT meeting - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Neurogene Announces Evidence-Based Monitoring And Treatment Intended To Reverse Rare Hyperinflammatory Syndrome Associated With High-Dose Aav - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Neurogene presents HLH treatment strategy at ASGCT meeting By Investing.com - Investing.com India

May 16, 2025
pulisher
May 16, 2025

Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV - Eagle-Tribune

May 16, 2025
pulisher
May 16, 2025

Neurogene (NGNE) Downgraded by Baird Amid Regulatory Concerns | - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Baird cuts Neurogene stock rating, lowers price target to $24 By Investing.com - Investing.com India

May 16, 2025
pulisher
May 16, 2025

Q2 Earnings Estimate for Neurogene Issued By HC Wainwright - Defense World

May 16, 2025
pulisher
May 15, 2025

Rett Syndrome treatment Market Is Booming Worldwide 2025-2032 | - openPR.com

May 15, 2025
pulisher
May 15, 2025

HC Wainwright Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock Price - Defense World

May 15, 2025
pulisher
May 13, 2025

Neurogene (NGNE) Analyst Rating Update: Target Price Adjusted | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Neurogene (NGNE) Target Price Reduced, Buy Rating Maintained | N - GuruFocus

May 13, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Purchases 1,397 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 11, 2025
pulisher
May 10, 2025

Barclays PLC Has $401,000 Position in Neurogene Inc. (NASDAQ:NGNE) - Defense World

May 10, 2025
pulisher
May 10, 2025

Neurogene: Q1 Earnings Snapshot - San Francisco Chronicle

May 10, 2025
pulisher
May 09, 2025

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 8, 2025 - BioSpace

May 09, 2025
pulisher
May 09, 2025

Neurogene Reports Q1 2025 Financial Results and Advances Rett Syndrome Gene Therapy - TipRanks

May 09, 2025
pulisher
May 09, 2025

NEUROGENE Earnings Results: $NGNE Reports Quarterly Earnings - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates - Business Wire

May 09, 2025
pulisher
May 07, 2025

Daily Market Movement: Neurogene Inc (NGNE) Sees a -13.63 Decrease, Closing at 13.05 - DWinneX

May 07, 2025
pulisher
May 07, 2025

10,475 Shares in Neurogene Inc. (NASDAQ:NGNE) Bought by Mariner LLC - Defense World

May 07, 2025
pulisher
May 06, 2025

Neurogene Inc expected to post a loss of $1.06 a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 02, 2025

Neurogene (NGNE) Expected to Announce Earnings on Friday - Defense World

May 02, 2025
pulisher
Apr 28, 2025

Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting - BioSpace

Apr 28, 2025
pulisher
Apr 28, 2025

Neurogene Announces Upcoming Oral Presentation On Monitoring And Treatment To Reverse Rare Complication Of High Dose Gene Therapy - marketscreener.com

Apr 28, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 26, 2025

Lost Money on Neurogene Inc. (NGNE)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 26, 2025

Neurogene Inc. (NASDAQ:NGNE) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 26, 2025
pulisher
Apr 22, 2025

Analysts Set Neurogene Inc. (NASDAQ:NGNE) Price Target at $47.20 - Defense World

Apr 22, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Grows Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - The AM Reporter

Apr 15, 2025
pulisher
Apr 15, 2025

BMO cuts Neurogene stock target to $16 from $45, keeps Outperform By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Increases Stock Holdings in Neurogene Inc. (NASDAQ:NGNE) - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

JPMorgan Chase & Co. Purchases 476,418 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

Neurogene (NASDAQ:NGNE) Given New $16.00 Price Target at BMO Capital Markets - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Neurogene Inc. Amends Agreement, Issues Warrants By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Neurogene Inc. Amends Agreement, Issues Warrants - Investing.com

Apr 14, 2025
pulisher
Apr 14, 2025

Neurogene Amends Agreement With Baker Bros To Increase Nomination Threshold - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

BMO cuts Neurogene stock target to $16 from $45, keeps Outperform - Investing.com Canada

Apr 14, 2025
pulisher
Apr 10, 2025

NGNE Stock Sees Decline of Approximately -13.67% in Last Five Days - knoxdaily.com

Apr 10, 2025
pulisher
Apr 07, 2025

NGNE stock touches 52-week low at $8.35 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

NGNE stock touches 52-week low at $8.35 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 03, 2025

Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome - BioSpace

Apr 03, 2025
pulisher
Apr 02, 2025

Neurogene reports progress in gene therapy regulation technology By Investing.com - Investing.com Canada

Apr 02, 2025

Neurogene Inc Azioni (NGNE) Dati Finanziari

Non sono disponibili dati finanziari per Neurogene Inc (NGNE). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.28
price down icon 1.54%
$30.93
price up icon 7.58%
$565.63
price up icon 0.69%
$3.99
price up icon 5.28%
$285.31
price up icon 0.67%
$71.31
price up icon 2.56%
Capitalizzazione:     |  Volume (24 ore):